|
新疆地区动脉血栓形成患者抗活化蛋白C及F Leiden 突变的调查 |
|
in the 3untranslation region of the prothrombin level and an increase in venous thrombosis [J]. Blood, 1996, 88:3698 3703.
[4] SEVENSSON PJ , DAHLBCK B. Resistance to activated protein C as a basis for venous thrombosis[J]. N Engl J Med,1994,330(8): 517522.
[5] BOKAREWA MI , BREMME K, FALK G, et al. Studies on phospholipids antibodies, APC resistance and associated mutation in the coagulation factor V gene[J]. Thromb Res, 1995, 78(3):193200.
[6] SELIGSOHN U, LUBETSKY A. Genetic susceptibility to venous thrombosis[J]. N Eng J Med,2001, 344:12221231.
[7] BERTINA RM, KOELEMAN BP, KOSTER T, et al. Mutation in blood coagulation factor Ⅴ associated with resistance to activated protein C [J]. Nature, 1994, 369 (6475): 6467.
[8] 马 艳,张庆华.新疆维吾尔族正常人群抗活化的蛋白C发生率的调查[J].中华血液学杂志, 1996, 17(9):468468.
[9] 邢颜超,马爱华,程维兴,等.凝血因子1691GA基因突变的研究分析[J].中国微循环杂志,2003,6(3):140142.
[10] 王振才,于福恩,姜超玲,等. 蛋白C?蛋白S?活化蛋白C抵抗与缺血性脑血管病的相关性研究[J]. 卒中与神经疾病,2004,11(6): 338341.
[11] CASTAMAN G, TOSETTO A, SIMIONI M, et al. in Carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thromb[J]. Haemost, 2001,86(3):804808.
[12] 李莉,李锦堂,刘瑞云,等. 凝血酶原20210A突变及其临床意义[J]. 血栓与止血学, 上一页 [1] [2] [3] [4] [5] [6] [7] 下一页 上一个医学论文: 新生小鼠心肌干细胞培养与分化的研究 下一个医学论文: 腔静脉滤器保护下介入治疗深静脉血栓形成
|
|
|